Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Neurology · Parkinson Disease 25, Autosomal Recessive, With Impaired Intellectual Development

Building Your Care Team and Preparing for Visits

At a Glance

For PARK25, coordinated care is especially important. Bring the complete genetic report, symptom and medication timeline, imaging files, and clear home videos to a movement-disorder specialist so the team can understand daily changes and plan support.

Managing an ultra-rare condition like PARK25 requires more than a single doctor; it requires a coordinated team of specialists who understand the intersection of movement disorders and neurodevelopmental features. Because PARK25 is so rare, you may find that you are teaching your local providers about the condition. Building a strong, multidisciplinary team ensures that every aspect of health is supported.

Your Core Specialized Team

The most critical member of your care team is a Movement Disorder Specialist. For children and adolescents, pediatric movement-disorder expertise is appropriate; for adults, an adult movement-disorder specialist is required, with a planned handoff to adult care when appropriate [1]. This specialist will oversee medication management, such as levodopa titration, and monitor for side effects like dyskinesia (involuntary movements) [2].

Other essential team members include:

  • Genetic Counselor: To help interpret complex genetic reports, discuss inheritance for other family members, and stay updated on PPP2R4 research [3][4].
  • Physical and Occupational Therapists (PT/OT): To focus on safety, balance, and fine motor skills. They can recommend adaptive equipment or exercises to manage muscle rigidity [5][6].
  • Speech-Language Pathologist (SLP): Crucial for monitoring swallowing and helping with communication challenges [7][8].
  • Neuropsychologist: To perform testing of cognitive and behavioral health, which helps in tailoring school or vocational support [9][10].
  • Social Worker or Care Coordinator: To help navigate the “diagnostic odyssey” and connect you with resources and transition planning [11].

Preparing for Your First Specialist Visit

The first visit with a movement disorder specialist is often long and detailed. To make the most of this time, you should arrive with specific records [12].

The Essential Paperwork Checklist:

  1. Original Genetic Test Reports: Do not bring just a summary. The specialist needs the full lab report showing the specific variants, the transcript ID, and whether parents were also tested [1][13].
  2. A Symptom Timeline: Note the approximate age when intellectual disability was first identified and when motor symptoms like stiffness or tremor began [12].
  3. Imaging and Lab Results: Bring copies of any brain MRIs (on a disc) and records from the Wilson-disease evaluation [14].
  4. Current Medication Log: List every medication, the exact dose, and the time it is taken. Note how long it takes for a dose to “kick in” and when it seems to “wear off” [2].

The Power of Home Video

Movement symptoms can change throughout the day and may not be fully visible during a short office visit. Home videos are one of the most valuable tools you can provide to a specialist [15][16].

When filming (ensuring you have consent when possible, and using fall precautions), try to capture:

  • Walking and Turning: Record walking toward and away from the camera, and making a full turn.
  • Hand Skills: Video a repetitive task, like tapping the finger and thumb together.
  • The ‘On/Off’ Cycle: If already taking medication, record when the medication is working well (“on”) and when it has worn off (“off”) [17].
  • Involuntary Movements: If you see new wiggling or jerky movements (dyskinesias), film these specifically [2].

Vetting Your Specialist

Because PARK25 is ultra-rare, the doctor’s willingness to listen and research is often more important than whether they have seen the condition before. A good specialist will welcome your engagement and recognize that you are the expert on daily life [11].

Common questions in this guide

Which specialists should be part of a PARK25 care team?
A movement-disorder specialist should lead medication and motor-symptom management. Depending on individual needs, the team may also include a genetic counselor, physical and occupational therapists, speech-language pathologist, neuropsychologist, and social worker or care coordinator. Pediatric and adult expertise may be needed at different stages.
What should I bring to the first PARK25 specialist appointment?
Bring the complete original genetic laboratory report, including the specific variants, transcript information, and whether parents were tested. Also bring a symptom timeline, brain imaging files, records from any Wilson disease evaluation, and a medication log with doses, times, benefits, and side effects.
How can home videos help with PARK25 care?
Movement symptoms can vary during the day and may not appear during a short office visit. With consent and fall precautions, record walking, turning, a hand task, medication on and off periods, and any involuntary movements so the specialist can review real-world changes.
What should I track about levodopa before a specialist visit?
Record the dose and time of each levodopa dose, how long it takes to help, how long the benefit lasts, and when symptoms return. Note any involuntary movements or other changes, and share the log with the care team rather than changing the dose without guidance.
How can doctors track progress when intellectual disability is also present?
Ask which movement and functional assessments are appropriate for the person’s abilities. Caregiver observations, home videos, and input from physical, occupational, and speech-language therapists can add important information about daily function.
How do I choose a specialist who has not treated PARK25 before?
Because PARK25 is extremely rare, a specialist may not have managed it previously. Look for a movement-disorder clinician who listens to the patient and family, is willing to research the condition, and can coordinate care with genetics, therapy, and support professionals.

Get notified when new evidence is published on Parkinson disease 25, autosomal recessive early-onset, with impaired intellectual development.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (17)
  1. 1

    Clinical and neuroimaging phenotypes of genetic parkinsonism from infancy to adolescence.

    Morales-Briceño H, Mohammad SS, Post B, et al.

    Brain : a journal of neurology 2020; (143(3)):751-770 doi:10.1093/brain/awz345.

    PMID: 31800013
  2. 2

    Levodopa-induced dyskinesia: clinical features, incidence, and risk factors.

    Tran TN, Vo TNN, Frei K, Truong DD

    Journal of neural transmission (Vienna, Austria : 1996) 2018; (125(8)):1109-1117 doi:10.1007/s00702-018-1900-6.

    PMID: 29971495
  3. 3

    Early Onset Parkinsonism: Differential diagnosis and what not to miss.

    Mohamed Ibrahim N, Lin CH

    Parkinsonism & related disorders 2024; (129()):107100 doi:10.1016/j.parkreldis.2024.107100.

    PMID: 39183141
  4. 4

    Diagnostic approach to paediatric movement disorders: a clinical practice guide.

    Brandsma R, van Egmond ME, Tijssen MAJ,

    Developmental medicine and child neurology 2021; (63(3)):252-258 doi:10.1111/dmcn.14721.

    PMID: 33150968
  5. 5

    Pediatric parkinsonism: clinical review and a proposed clinical algorithm.

    Naranjo-Lobo V, Hidalgo-Bravo MJ, Munoz-Chesta D, Troncoso-Schifferli M

    Frontiers in neurology 2026; (17()):1788936 doi:10.3389/fneur.2026.1788936.

    PMID: 42483444
  6. 6

    Comparison of disability level between Early and Late Onset Parkinson's Disease using WHODAS 2.

    Nascimento IAPDS, Nobrega KCC, Souza BRA, et al.

    Frontiers in neurology 2023; (14()):1281537 doi:10.3389/fneur.2023.1281537.

    PMID: 38033768
  7. 7

    A novel variant of PLA2G6 gene related early-onset parkinsonism: a case report and literature review.

    Cai D, Wu H, Huang B, et al.

    Frontiers in neurology 2024; (15()):1349861 doi:10.3389/fneur.2024.1349861.

    PMID: 38699051
  8. 8

    Expanding the Clinical and Mutational Spectrum of FBXO7-Related Parkinsonism: A Novel Italian Family and Comprehensive Literature Review.

    Zampatti S, Strafella C, Campopiano R, et al.

    Genes 2026; (17(7)) doi:10.3390/genes17070764.

    PMID: 42510804
  9. 9

    Pediatric-Onset Epilepsy and Developmental Epileptic Encephalopathies Followed by Early-Onset Parkinsonism.

    Spagnoli C, Fusco C, Pisani F

    International journal of molecular sciences 2023; (24(4)) doi:10.3390/ijms24043796.

    PMID: 36835207
  10. 10

    Novel Homozygous Pathogenic Variant in DNAJC6 Causes Rapid Progressive Parkinsonism.

    Pessoa ALS, Guimarães TG, de Castro Dos Santos D, et al.

    Movement disorders clinical practice 2026; doi:10.1002/mdc3.70731.

    PMID: 42414182
  11. 11

    Young Onset Parkinson's Disease: A Modern and Tailored Approach.

    Post B, van den Heuvel L, van Prooije T, et al.

    Journal of Parkinson's disease 2020; (10(s1)):S29-S36 doi:10.3233/JPD-202135.

    PMID: 32651336
  12. 12

    [Movement disorders in children].

    Gras D

    La Revue du praticien 2020; (70(6)):647-652.

    PMID: 33058611
  13. 13

    Phenotypic and Genetic Complexity in Pediatric Movement Disorders.

    Kim MJ, Yum MS, Seo GH, et al.

    Frontiers in genetics 2022; (13()):829558 doi:10.3389/fgene.2022.829558.

    PMID: 35719373
  14. 14

    Clinical Management of Dystonia in Childhood.

    Luc QN, Querubin J

    Paediatric drugs 2017; (19(5)):447-461 doi:10.1007/s40272-017-0243-3.

    PMID: 28620849
  15. 15

    Movement Disorders Presenting in Childhood.

    Kurian MA, Dale RC

    Continuum (Minneapolis, Minn.) 2016; (22(4 Movement Disorders)):1159-85 doi:10.1212/CON.0000000000000367.

    PMID: 27495203
  16. 16

    French virtual multidisciplinary team meeting for pediatric movement disorders (PMD-vMDT): a three-year survey.

    François-Heude MC, Lecardonnel B, Papathanasiou M, et al.

    Frontiers in neurology 2025; (16()):1751665 doi:10.3389/fneur.2025.1751665.

    PMID: 41607847
  17. 17

    The Genetic Landscape of Complex Childhood-Onset Hyperkinetic Movement Disorders.

    Pérez-Dueñas B, Gorman K, Marcé-Grau A, et al.

    Movement disorders : official journal of the Movement Disorder Society 2022; (37(11)):2197-2209 doi:10.1002/mds.29182.

    PMID: 36054588

This page is for education about organizing care for PARK25 and does not replace medical advice. A movement-disorder specialist and your care team should interpret symptoms, test results, medication effects, and treatment decisions for your situation.